6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/08 (2006.01) A61K 31/33 (2006.01) A61P 5/00 (2006.01)

Patent

CA 2696288

In its many embodiments, the present invention relates to a novel class of 6-substituted sulfonyl-1,3,3-trialkyl-6-az-abicyclo[3.2.1]octane compounds useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-I, pharmaceutical compositions contain-ing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the expression of 11.beta.-hydroxysteroid dehydrogenase type-I using such compounds or pharmaceutical compositions.

L'invention concerne, dans ses nombreux modes de réalisation, une nouvelle classe de composés de sulfonyl-1,3,3-trialkyl-6-azabicyclo[3.2.1]octane substitués en position 6 utiles pour inhiber la 11b-hydroxystéroïde déshydrogénase de type I, des compositions pharmaceutiques contenant les composés, et des procédés de traitement, de prévention, d'inhibition, ou d'amélioration d'un ou de plusieurs affections associées à l'expression de la 11b-hydroxystéroïde déshydrogénase de type I en utilisant de tels composés ou compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1704911

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.